WittGen
WittGen Biotechnologies utilizes a single-cell RNA sequencing data analysis and testing to overcome the heterogeneity of cancer.
Seed ·
Amount not disclosed in a source on record.
All 2 rounds ↓Signals
Website registeredMar 23, 2022 (4 years old)
Funding rounds
- Seed · amount undisclosed
- Indianapolis
PPlug and Play · batch
Source: public.dxp.playbook.vc - Website created
Founders and team
YR
Yun Rhie Co-founder & CEOsource: wittgenbio.comMJ
Minwoo Jung Co-founder & CTOsource: wittgenbio.comMK
Minjun Kim Founder
Investors
Companies like WittGen
AArgenTAG
SSingleron Biotechnologies$100M Series B+ · Nov 2021
AAlethio Therapeutics$90M Series A · Nov 2026
LLightcast$27M Series B+ · Apr 2026
1100XBIOPre Seed · Oct 2026
IImmuno Cancer BiotherapeuticsSeed · Oct 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/wittgen (get a free API key).